We have studied the hydrogen bond interactions of (15)N labeled 4-methylpyridine (4-MP) with pentachlorophenol (PCP) in the solid state and in polar solution using various NMR techniques. Previous spectroscopic, X-ray, and neutron crystallographic studies showed that the triclinic 1:1 complex (4-MPPCP) exhibits the strongest known intermolecular OHN hydrogen bond in the solid state. By contrast, deuteration of the hydrogen bond gives rise to the formation of a monoclinic structure exhibiting a weaker hydrogen bond. By performing NMR experiments at different deuterium fractions and taking advantage of dipolar (1)H-(15)N recoupling under combined fast MAS and (1)H decoupling, we provide an explanation of the origin of the isotopic polymorphism of 4-MPPCP and improve previous chemical shift correlations for OHN hydrogen bonds. Because of anharmonic ground state vibrations, an ODN hydrogen bond in the triclinic form exhibits a shorter oxygen-hydron and a longer oxygen-nitrogen distance as compared to surrounding OHN hydrogen bonds, which also implies a reduction of the local dipole moment. The dipole-dipole interaction between adjacent coupled OHN hydrogen bonds which determines the structure of triclinic 4-MPPCP is then reduced by deuteration, and other interactions become dominant, leading to the monoclinic form. Finally, the observation of stronger OHN hydrogen bonds by (1)H NMR in polar solution as compared to the solid state is discussed.
LysCel is a cellulose-based material in which l-lysine molecules are grafted with their amino side chains to the cellulose hydroxyl groups. This modification increases considerably the mechanical strength and resistance of cellulosic structures toward water. It has been attributed to the formation of double salt bridges between lysine aminocarboxyl groups in the zwitterionic state. In order to characterize this unusual structure, we have performed high-resolution solid-state (15)N and (13)C CPMAS NMR experiments on LysCel samples labeled with (15)N in the alpha-position or epsilon-position. Furthermore, (13)C-(15)N REDOR experiments were performed on LysCel where half of the aminocarboxyl groups were labeled in 1-position with 13C and the other half in alpha-position with (15)N. The comparison with the 13C and 15N chemical shifts of l-leucine lyophilized at different pH shows that the aminocarboxyl groups of LysCel are indeed zwitterionic. The REDOR experiments indicate distances of about 3.5 A between the carboxyl carbon and the nitrogen atoms of different aminocarboxyl groups, indicating that the latter are in close contact with each other. However, the data are not compatible with isolated aminocarboxyl dimers but indicate the assembly of zwitterionic aminocarboxyl dimers either in a flat ribbon or as tetramers, exhibiting similar intra- and interdimer (13)C...(15)N distances. This interaction of several aminocarboxyl groups is responsible for the zwitterionic state, in contrast to the gas phase, where amino acid dimers exhibiting two OHN hydrogen bonds are neutral.
Signal amplification by reversible exchange (SABRE) can enhance nuclear magnetic resonance signals by several orders of magnitude. However, until now this was limited to a small number of model target molecules. Here, a new convenient method for SABRE activation applicable to a variety of synthetic model oligopeptides is demonstrated. For the first time, a highly SABRE-active pyridine-based biocompatible molecular framework is incorporated into synthetic oligopeptides. The SABRE activity is preserved, demonstrating the importance of such earmarking. Finally, a crucial exchange process responsible for SABRE activity is identified and discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.